TRETINOIN MICROSPHERE Drug Patent Profile
When do Tretinoin Microsphere patents expire, and when can generic versions of Tretinoin Microsphere launch?
Tretinoin Microsphere is a drug marketed by Encube and is included in one NDA.
The generic ingredient in TRETINOIN MICROSPHERE is tretinoin. There is one drug master file entry for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tretinoin Microsphere
A generic version of TRETINOIN MICROSPHERE was approved as tretinoin by PADAGIS US on December 24th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRETINOIN MICROSPHERE?
- What are the global sales for TRETINOIN MICROSPHERE?
- What is Average Wholesale Price for TRETINOIN MICROSPHERE?
Summary for TRETINOIN MICROSPHERE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 6 |
| Drug Prices: | Drug price information for TRETINOIN MICROSPHERE |
| DailyMed Link: | TRETINOIN MICROSPHERE at DailyMed |
Recent Clinical Trials for TRETINOIN MICROSPHERE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Taro Pharmaceuticals USA | Early Phase 1 |
| Galderma Laboratories, L.P. | Phase 4 |
| Spear Pharmaceuticals | Phase 3 |
Pharmacology for TRETINOIN MICROSPHERE
| Drug Class | Retinoid |
US Patents and Regulatory Information for TRETINOIN MICROSPHERE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Encube | TRETINOIN MICROSPHERE | tretinoin | GEL;TOPICAL | 215609-002 | Apr 15, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Encube | TRETINOIN MICROSPHERE | tretinoin | GEL;TOPICAL | 215609-001 | Aug 22, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
